Benzonatate Production Cost Reports

The report provides a detailed analysis essential for establishing a benzonatate production plant. It encompasses all critical aspects necessary for benzonatate production, including the cost of benzonatate production, benzonatate plant cost, benzonatate production costs, and the overall benzonatate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a benzonatate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Benzonatate is a non-narcotic oral medication that is mainly used to relieve cough. It is primarily utilised as an antitussive agent to relieve cough caused by common cold, flu, bronchitis, and other respiratory conditions. Its main application is in suppressing dry, irritating cough by numbing the stretch receptors in the lungs and airways, which helps decrease the cough reflex. It works by anaesthetising the stretch receptors in the lungs and air passages, thereby suppressing the cough reflex. It is generally formulated in softgel capsules for oral use and is suitable for short-term treatment. In addition, it is often used in combination with other medications in certain formulations for managing symptoms of upper respiratory tract infections. It is also included as part of supportive care in various respiratory disorders to provide symptomatic relief. It helps improve patient comfort by reducing throat irritation and chest discomfort linked to frequent coughing. Moreover, it is widely prescribed in hospitals and clinics to manage dry and persistent cough in adults and children above 10 years of age.

The market for benzonatate is mainly driven by its demand as a cough suppressant for the symptomatic relief of dry and persistent cough in patients over the age of 10 years. Its usage as an antitussive agent to reduce coughing associated with common cold, bronchitis, pneumonia, and other respiratory infections significantly boosts its demand in the pharmaceutical industry. Its application as an oral drug to reduce the cough reflex by numbing the throat and lungs further drives its demand in the respiratory care and medical sectors. Its demand as a drug in supportive treatment plans for various respiratory infections to improve patient comfort also contributes to its market expansion.

The rising prevalence of seasonal flu, common cold, and other respiratory disorders also contributes to higher consumption in the healthcare sector. Additionally, industrial benzonatate procurement is influenced by factors such as the cost and availability of active pharmaceutical ingredients, regulatory approvals, quality standards, and compliance with production guidelines. Advancements in drug formulation, reliable supplier networks, sustainable production practices, and efficient distribution systems also play an important role in shaping the global procurement strategies for benzonatate.

Raw Material for Benzonatate Production

According to the benzonatate production plant project report, the major raw materials for benzonatate production include 4-butylaminobenzoic acid and nonaethylene glycol monomethyl ether.

Production Process of Benzonatate

The extensive benzonatate production cost report consists of the following industrial production process:

1. Production via Re-esterification: The production process of benzonatate begins with the preparation of the ethyl ester of 4-butylaminobenzoic acid, which serves as the main starting material. Then, this intermediate is reacted with monomethyl ether of nonaethylene glycol in a controlled re-esterification step, where the ethyl group is replaced to form the desired long-chain ester structure. The reaction mixture is maintained under suitable conditions to ensure complete conversion and proper bonding of the glycol chain to the benzoate core. After the reaction is complete, the product is purified to remove unreacted materials and by-products through filtration and other standard purification techniques. Then, the purified compound is dried and processed into its final pharmaceutical form to obtain benzonatate.

Benzonatate is a synthetic butylamino-benzoate derivative that acts as a non-narcotic antitussive (cough suppressant). It appears as a white to off-white crystalline powder. The molecular formula of the compound is C30H53NO11, and its molar mass is 603.74 g/mol. It is marketed under the brand name Tessalon. Its density is approximately 1.096 g/cm³, and it has a melting point of 106–109 degree Celsius. The boiling point of the compound is approximately 649 degree Celsius at 760 mmHg, and its flash point is approximately 346.3 degree Celsius. It is practically insoluble in water, with a solubility of only about 0.005 mg/mL at 20 degree Celsius, but it is soluble in ethanol, methanol, toluene, and chloroform. The compound is extremely dangerous in overdose, particularly in children below 10 years of age, and accidental ingestion resulting in death has been reported. Chewing or sucking on the capsule instead of swallowing it whole can cause severe hypersensitivity reactions, including laryngospasm, bronchospasm, and cardiovascular collapse. Common side effects include drowsiness, dizziness, headache, and nausea. It is recommended to store the compound at controlled room temperature and to keep it out of the reach of children.